ANTIPARKINSON AGENTS. C7B. DECARBOXYLASE INHIBITORS. YES. H6A. ANTIPARKINSONISM DRUGS,OTHER. YES. H6B. ANTIPARKINSONISM DRUGS,ANTICHOLINERGIC. YES. 11.
Dopaminergic antiparkinsonism agents aim to replace dopamine or prevent the degradation of dopamine. Antiparkinson drugs that aim to replace dopamine in the
Adjunct antiparkinson agents are indicated as add-on therapy in people with Parkinson's disease who are already on other antiparkinson drugs like levodopa and
Types of Antiparkinson agents anticholinergic antiparkinson agents dopaminergic antiparkinsonism agents miscellaneous antiparkinson agents. Further
What are Antiparkinson agents? Antiparkinson agents aim to replace dopamine either by drugs that release dopamine or those that mimic the action of dopamine.
antiparkinson drug, any drug used to treat the symptoms of Parkinson disease or other conditions of parkinsonism. The major antiparkinson drugs are levodopa
antiparkinson medications available. Introduction Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs.
MeSH terms Antiparkinson Agents / adverse effects Antiparkinson Agents / pharmacokinetics
Anticholinergic drugs block the effect of Antiparkinson drugs Antiparkinson drugs Medications for the management of Parkinson's disease
Comments